DOI QR코드

DOI QR Code

Genetic Analysis of 10 Unrelated Korean Families with p22-phox-deficient Chronic Granulomatous Disease: An Unusually Identical Mutation of the CYBA Gene on Jeju Island, Korea

Kim, Young-Mee;Park, Ji-Eun;Kim, Jin-Young;Lim, Hee-Kyung;Nam, Jae-Kook;Cho, Moon-Jae;Shin, Kyung-Sue

  • Published : 2009.11.07

Abstract

Chronic granulomatous disease (CGD) is a rare hereditary disorder characterized by recurrent life-threatening bacterial and fungal infections. The underlying defect in CGD is an inability of phagocytes to produce reactive oxygen species as a result of defects in NADPH oxidase. Considering that CGD generally affects about 3-4 in 1,000,000 individuals, it is surprising that the prevalence of CGD on Jeju Island is 20.7 in 1,000,000 individuals. We performed genetic analysis on 12 patients from 10 unrelated families and found that all patients had an identical homozygous single- base substitution of C to T in exon 1 (c.7C>T) of the CYBA gene, which was expected to result in a nonsense mutation (p.Q3X). Because Jeju Island has long been a geologically isolated region, the high prevalence of CGD on Jeju Island is presumably associated with an identical mutation inherited from a common ancestor or proband.

Keywords

References

  1. Roos D, Kuijpers TW, Curnutte JT. Chronic granulomatous disease. In: Ochs HD, Smith CI, Puck JM, eds, Primary Immunodeficiency Diseases, a Molecular and Genetic Approach. New York: Oxford University Press 2007; 525-49.
  2. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000; 79: 170-200. https://doi.org/10.1097/00005792-200005000-00004
  3. Lapouge K, Smith SJ, Groemping Y, Rittinger K. Architecture of the p40-p47-p67phox complex in the resting state of the NADPH oxidase, a central role for p67phox. J Biol Chem 2002; 277: 10121-8. https://doi.org/10.1074/jbc.M112065200
  4. Heyworth PG, Cross AR, Curnutte JT. Chronic granulomatous disease. Curr Opin Immunol 2003; 15: 578-84. https://doi.org/10.1016/S0952-7915(03)00109-2
  5. Robinson JM, Ohira T, Badwey JA. Regulation of the NADPH-oxidase complex of phagocytic leukocytes. Recent insights from structural biology, molecular genetics, and microscopy. Histochem Cell Biol 2004; 122: 293-304. https://doi.org/10.1007/s00418-004-0672-2
  6. Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, Buckley RH, Foster CB, Chanock SJ, Dickler H. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79: 155-69. https://doi.org/10.1097/00005792-200005000-00003
  7. Hasui M. Chronic granulomatous disease in Japan: incidence and natural history. The study group of Phagocyte Disorders of Japan. Pediatr Int 1999; 41: 589-93. https://doi.org/10.1046/j.1442-200x.1999.01129.x
  8. Ahlin A, De Boer M, Roos D, Lensen J, Smith CL, Sundin U, Rabbani H, Palmblad J, Elinder G. Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr 1995; 84: 1386-94. https://doi.org/10.1111/j.1651-2227.1995.tb13575.x
  9. Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, Rossi P, Gattorno M, Rabusin M, Azzari C, Dellepiane RM, Pietrogrande MC, Trizzino A, Di Bartolomeo P, Martino S, Carpinom L, Cossun F, Locatelli F, Maccario R, Pierani P, Putti MC, Stabile A, Notarangelo LD, Ugazio AG, Plebani A, De Mattia D, IPINET. Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. Clin Immunol 2008; 126: 155-64. https://doi.org/10.1016/j.clim.2007.09.008
  10. Wolach B, Gavrieli R, de Boer M, Gottesman G, Ben-Ari J, Rottem M, Schlesinger Y, Grisaru-Soen G, Etzioni A, Roos D. Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients. Clin Immunol 2008; 129: 103-14. https://doi.org/10.1016/j.clim.2008.06.012
  11. El Kares R, Barbouche MR, Elloumi-Zghal H, Bejaoui M, Chemli J, Mellouli F, Tebib N, Abdelmoula MS, Boukthir S, Fitouri Z, M'Rad S, Bouslama K, Touiri H, Abdelhak S, Dellagi MK. Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia. J Hum Genet 2006; 51: 887-95. https://doi.org/10.1007/s10038-006-0039-8
  12. Vowells SJ, Sekhsaria S, Malech HL, Shalit M, Fleisher TA. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods 1995; 178: 89-97. https://doi.org/10.1016/0022-1759(94)00247-T
  13. Rae J, Noack D, Heyworth PG, Ellis BA, Curnutte JT, Cross AR. Molecular analysis of nine new families with chronic granulomatous disease caused by mutations in CYBA, the gene encoding p22 (phox). Blood 2000; 96: 1106-12.
  14. Yamada M, Ariga T, Kawamura N, Ohtsu M, Imajoh-Ohmi S, Ohshika E, Tatsuzawa O, Kobayashi K, Sakiyama Y. Genetic studies of three Japanese patients with p22-phox-deficient chronic granulomatous disease: detection of a possible common mutant CYBA allele in Japan and a genotype-phenotype correlation in these patients. Br J Haematol 2000; 108: 511-7. https://doi.org/10.1046/j.1365-2141.2000.01857.x
  15. Ishibashi F, Nunoi H, Endo F, Matsuda I, Kanegasaki S. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency. Hum Genet 2000; 106: 478-81.
  16. Teimourian S, Zomorodian E, Badalzadeh M, Pouya A, Kannengiesser C, Mansouri D, Cheraghi T, Parvaneh N. Characterization of six novel mutations in CYBA: the gene causing autosomal recessive chronic granulomatous disease. Br J Haematol 2008; 141: 848-51. https://doi.org/10.1111/j.1365-2141.2008.07148.x
  17. Yu L, Quinn MT, Cross AR, Dinauer MC. Gp91(phox) is the heme binding subunit of the superoxide-generating NADPH oxidase. Proc Natl Acad Sci USA 1998; 95: 7993-8. https://doi.org/10.1073/pnas.95.14.7993
  18. Kim JG, Shin KS, Park JS. Clinical study on chronic granulomatous disease in Korea. Korean J Immunol 1999; 21: 271-83.
  19. Lee SY, Choi EY, Go SH, Rhim JW, Lee SD, Kim JG. A case of Xlinked chronic granulomatous disease diagnosed in identical twin. Infect Chemother 2007; 39: 332-7.
  20. Oh HB, Park JS, Lee W, Yoo SJ, Yang JH, Oh SY. Molecular analysis of X-linked chronic granulomatous disease in five unrelated Korean patients. J Korean Med Sci 2004; 19: 218-22. https://doi.org/10.3346/jkms.2004.19.2.218
  21. De Boer M, De Klein A, Hossle JP, Seger R, Corbeel L, Weening RS, Roos D. Cytochrome b558-negative, autosomal recessive chronic granulomatous disease: two new mutations in the cytochrome b558 light chain of the NADPH oxidase (p22-phox). Am J Hum Genet 1992; 51: 1127-35.

Cited by

  1. Development of a Lentiviral Vector and an Efficient Infection Method for Gene Therapy for p22phox-defective Chronic Granulomatous Disease vol.55, pp.4, 2009, https://doi.org/10.1007/s13765-012-2098-1
  2. New Method for Detection of p22-phox-deficient Chronic Granulomatous Disease Heterozygote Carriers in Jeju vol.55, pp.5, 2009, https://doi.org/10.1007/s13765-012-2134-1
  3. Infections associated with chronic granulomatous disease: linking genetics to phenotypic expression vol.10, pp.8, 2009, https://doi.org/10.1586/eri.12.77
  4. Chronic Granulomatous Disease on Jeju Island, Korea vol.10, pp.1, 2009, https://doi.org/10.5734/jgm.2013.10.1.1
  5. Identification of a Novel Mutation in the CYBB Gene, p.Asp378Gly, in a Patient With X-linked Chronic Granulomatous Disease vol.6, pp.4, 2014, https://doi.org/10.4168/aair.2014.6.4.366
  6. Long-term outcome of patients with p22phox-deficient chronic granulomatous disease on Jeju Island, Korea vol.58, pp.4, 2009, https://doi.org/10.3345/kjp.2015.58.4.129
  7. Role of Flow Cytometry in the Diagnosis of Chronic Granulomatous Disease: the Egyptian Experience vol.36, pp.6, 2016, https://doi.org/10.1007/s10875-016-0297-y
  8. A Founder Effect of c.257 + 2T > C Mutation in NCF2 Gene Underlies Severe Chronic Granulomatous Disease in Eleven Patients vol.36, pp.6, 2009, https://doi.org/10.1007/s10875-016-0299-9
  9. Concomitant use of corticosteroid and antimicrobials for liver abscesses in patients with chronic granulomatous disease vol.59, pp.4, 2009, https://doi.org/10.3345/kjp.2016.59.4.196
  10. Recent advances in understanding and treating chronic granulomatous disease vol.6, pp.None, 2017, https://doi.org/10.12688/f1000research.11789.1
  11. Mastoidectomy in a child with chronic granulomatous disease vol.78, pp.10, 2009, https://doi.org/10.12968/hmed.2017.78.10.586
  12. Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update) vol.92, pp.None, 2009, https://doi.org/10.1016/j.bcmd.2021.102596